Concepedia

Paul E. Hanna

PE

Statistics

Publications

5

Citations

89

H-Index

5

Active since

2023

Affiliations

Massachusetts General Hospital(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Paul E. Hanna is an author at Massachusetts General Hospital specializing in cancer therapeutics, cancer research, and medicine.

ORCID

Top concepts

Publications per year

2023–2024

5

Publications

5

Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer

Paul E. Hanna, Qiyu Wang, Ian A. Strohbehn et al. · JAMA Network Open · 2023 · 27 citations · Full text

Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer

Paul E. Hanna, Tianqi Ouyang, Ismail Tahir et al. · Journal of Cachexia Sarcopenia and Muscle · 2024 · 19 citations · Full text

Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors

Shruti Gupta, Paul E. Hanna, Tianqi Ouyang et al. · JNCI Journal of the National Cancer Institute · 2023 · 16 citations · Full text

, , +22

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer

Paul E. Hanna, Ian A. Strohbehn, Daiana Moreno et al. · npj Breast Cancer · 2023 · 16 citations · Full text

Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study

Bruce C. Tiu, Ian A. Strohbehn, Sophia Zhao et al. · The Oncologist · 2023 · 11 citations · Full text

1–5 of 5